FABIANA AGENA
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina
2 resultados
Resultados de Busca
Agora exibindo 1 - 2 de 2
- Recurrence of IgA Nephropathy after Kidney Transplantation in Adults(2021) UFFING, Audrey; PEREZ-SAEZ, Maria Jose; JOUVE, Thomas; BUGNAZET, Mathilde; MALVEZZI, Paolo; MUHSIN, Saif A.; LAFARGUE, Marie-Camille; REINDL-SCHWAIGHOFER, Roman; MORLOCK, Alina; OBERBAUER, Rainer; BUXEDA, Anna; BURBALLA, Carla; PASCUAL, Julio; MOOS, Seraina von; SEEGER, Harald; MANNA, Gaetano La; COMAI, Giorgia; BINI, Claudia; RUSSO, Luis Sanchez; FAROUK, Samira; NISSAISORAKARN, Pitchaphon; PATEL, Het; AGRAWAL, Nikhil; MASTROIANNI-KIRSZTAJN, Gianna; MANSUR, Juliana; TEDESCO-SILVA, Helio; VENTURA, Carlucci Gualberto; AGENA, Fabiana; DAVID-NETO, Elias; AKALIN, Enver; ALANI, Omar; MAZZALI, Marilda; MANFRO, Roberto Ceratti; BAUER, Andrea Carla; WANG, Aileen X.; CHENG, Xingxing S.; SCHOLD, Jesse D.; BERGER, Stefan P.; CRAVEDI, Paolo; RIELLA, Leonardo V.Background and objectives In patients with kidney failure due to IgA nephropathy, IgA deposits can recur in a subsequent kidney transplant. The incidence, effect, and risk factors of IgA nephropathy recurrence is unclear, because most studies have been single center and sample sizes are relatively small. Design, setting, participants, & measurements We performed a multicenter, international, retrospective study to determine the incidence, risk factors, and treatment response of recurrent IgA nephropathy after kidney transplantation. Data were collected from all consecutive patients with biopsy-proven IgA nephropathy transplanted between 2005 and 2015, across 16 ""The Post-Transplant Glomerular Disease"" study centers in Europe, North America, and South America. Results Out of 504 transplant recipients with IgA nephropathy, recurrent IgA deposits were identified by kidney biopsy in 82 patients; cumulative incidence of recurrence was 23% at 15 years (95% confidence interval, 14 to 34). Multivariable Cox regression revealed a higher risk for recurrence of IgA deposits in patients with a pre-emptive kidney transplant (hazard ratio, 3.45; 95% confidence interval, 1.31 to 9.17) and in patients with preformed donor-specific antibodies (hazardratio, 2.59; 95% confidence interval, 1.09 to 6.19). After kidney transplantation, development of de novo donor-specific antibodies was associated with subsequent higher risk of recurrence of IgA nephropathy (hazard ratio, 6.65; 95% confidence interval, 3.33 to 13.27). Immunosuppressive regimen was not associated with recurrent IgA nephropathy in multivariable analysis, including steroid use. Graft loss was higher in patients with recurrence of IgA nephropathy compared with patients without (hazard ratio, 3.69; 95% confidence interval, 2.04 to 6.66), resulting in 32% (95% confidence interval, 50 to 82) graft loss at 8 years after diagnosis of recurrence. Conclusions In our international cohort, cumulative risk of IgA nephropathy recurrence increased after transplant and was associated with a 3.7-fold greater risk of graft loss.
- Recurrence of FSGS after Kidney Transplantation in Adults(2020) UFFING, Audrey; PEREZ-SAEZ, Maria Jose; MAZZALI, Marilda; MANFRO, Roberto C.; BAUER, Andrea Carla; DRUMOND, Frederico de Sottomaior; O'SHAUGHNESSY, Michelle M.; CHENG, Xingxing S.; CHIN, Kuo-Kai; VENTURA, Carlucci G.; AGENA, Fabiana; DAVID-NETO, Elias; MANSUR, Juliana B.; KIRSZTAJN, Gianna Mastroianni; JR, Helio Tedesco-Silva; V, Gilberto M. Neto; ARIAS-CABRALES, Carlos; BUXEDA, Anna; BUGNAZET, Mathilde; JOUVE, Thomas; MALVEZZI, Paolo; AKALIN, Enver; ALANI, Omar; AGRAWAL, Nikhil; MANNA, Gaetano La; COMAI, Giorgia; BINI, Claudia; MUHSIN, Saif A.; RIELLA, Miguel Carlos; HOKAZONO, Silvia R.; FAROUK, Samira S.; HAVERLY, Meredith; MOTHI, Suraj Sarvode; BERGER, Stefan P.; CRAVEDI, Paolo; V, Leonardo RiellaBackground and objectivesFSGS recurrence after kidney transplantation is a major risk factor for graft loss. However, the natural history, clinical predictors, and response to treatment remain unclear because of small sample sizes and poor generalizability of single-center studies, and disease misclassification in registry-based studies. We therefore aimed to determine the incidence, predictors, and treatment response of recurrent FSGS in a large cohort of kidney transplant recipients.Design, setting, participants, & measurementsThe Post-Transplant Glomerular Disease (TANGO) project is an observational, multicenter, international cohort study that aims to investigate glomerular disease recurrence post-transplantation. Transplant recipients were screened for the diagnosis of idiopathic FSGS between 2005 and 2015 and details were recorded about the transplant, clinical outcomes, treatments, and other risk factors.ResultsAmong 11,742 kidney transplant recipients screened for FSGS, 176 had a diagnosis of idiopathic FSGS and were included. FSGS recurred in 57 patients (32%; 95% confidence interval [95% CI], 25% to 39%) and 39% of them lost their graft over a median of 5 (interquartile range, 3.0?8.1) years. Multivariable Cox regression revealed a higher risk for recurrence with older age at native kidney disease onset (hazard ratio [HR], 1.37 per decade; 95% CI, 1.09 to 1.56). Other predictors were white race (HR, 2.14; 95% CI, 1.08 to 4.22), body mass index at transplant (HR, 0.89 per kg/m(2); 95% CI, 0.83 to 0.95), and native kidney nephrectomies (HR, 2.76; 95% CI, 1.16 to 6.57). Plasmapheresis and rituximab were the most frequent treatments (81%). Partial or complete remission occurred in 57% of patients and was associated with better graft survival.ConclusionsIdiopathic FSGS recurs post-transplant in one third of cases and is associated with a five-fold higher risk of graft loss. Response to treatment is associated with significantly better outcomes but is achieved in only half of the cases.